Brain-targeted delivery of obidoxime, using aptamer-modified liposomes, for detoxification of organophosphorus compounds

被引:41
作者
Zhang, Yadan [1 ,2 ]
He, Junlin [1 ,2 ]
Shen, Liao [1 ,2 ]
Wang, Tao [1 ,2 ]
Yang, Jun [1 ,2 ]
Li, Yao [1 ,2 ]
Wang, Yongan [1 ,2 ]
Quan, Dongqin [1 ,2 ]
机构
[1] Acad Mil Med Sci, Inst Pharmacol & Toxicol, Beijing 100850, Peoples R China
[2] State Key Lab Toxicol & Med Counter Measures, Beijing 100850, Peoples R China
关键词
Organophosphorus poisoning; Blood-brain barrier; Obidoxime; Aptamer; Liposomes; Brain-targeted delivery; BARRIER PENETRATION; OXIME; THERAPEUTICS; EFFICACY; HI-6;
D O I
10.1016/j.jconrel.2020.10.039
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Effective intracerebral delivery acetylcholinesterase (AChE) reactivator is key for the acute organophosphorus (OPs) poison treatment. However, the blood-brain barrier (BBB) restricts the transport of these drugs from blood into the brain. Herein, we developed transferrin receptor (TfR) aptamer-functionalized liposomes (Apt-LP) that could deliver AChE reactivator (obidoxime) across the BBB to act against paraoxon (POX) poisoning. The aptamer had strong affinity for TfR and was modified with 3'-inverted deoxythymidine (dT) to improve serum stability. The uptake of Apt-LP by bEnd.3 cells was significantly higher than that of non-targeting liposomes. The ability of Apt-LP to penetrate intact BBB was confirmed in in vitro BBB mice model and in vivo biodistribution studies. Treatment of POX-poisoned mice with Apt-LP-LuH-6 reactivated 18% of the brain AChE activity and prevented brain damage to some extent. Taken together, these results showed that Apt-LP may be used as a promising brain-targeted drug delivery system against OPs toxicity.
引用
收藏
页码:1117 / 1128
页数:12
相关论文
共 30 条
[1]   Nanoformulation properties, characterization, and behavior in complex biological matrices: Challenges and opportunities for brain-targeted drug updates delivery applications and enhanced translational potential [J].
Agrahari, Vibhuti ;
Burnouf, Pierre-Alain ;
Burnouf, Thierry ;
Agrahari, Vivek .
ADVANCED DRUG DELIVERY REVIEWS, 2019, 148 :146-180
[2]   Recent strategies and advances in the fabrication of nano lipid carriers and their application towards brain targeting [J].
Agrawal, Mukta ;
Saraf, Swarnlata ;
Saraf, Shailendra ;
Dubey, Sunil Kumar ;
Puri, Anu ;
Patel, Ravish J. ;
Ajazuddina ;
Ravichandiran, V. ;
Murty, Upadhyayula Suryanarayana ;
Alexander, Amit .
JOURNAL OF CONTROLLED RELEASE, 2020, 321 :372-415
[3]   Reversible Cell-Specific Drug Delivery with Aptamer-Functionalized Liposomes [J].
Cao, Zehui ;
Tong, Rong ;
Mishra, Abhijit ;
Xu, Weichen ;
Wong, Gerard C. L. ;
Cheng, Jianjun ;
Lu, Yi .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2009, 48 (35) :6494-6498
[4]   TBA loop mapping with 3′-inverted-deoxythymidine for fine-tuning of the binding affinity for α-thrombin [J].
Chai, Zhilong ;
Guo, Lei ;
Jin, Hongwei ;
Li, Yang ;
Du, Shanshan ;
Shi, Yucong ;
Wang, Chuhan ;
Shi, Weiguo ;
He, Junlin .
ORGANIC & BIOMOLECULAR CHEMISTRY, 2019, 17 (09) :2403-2412
[5]   Intrathecal drug delivery in the era of nanomedicine [J].
Fowler, M. J. ;
Cotter, J. D. ;
Knight, B. E. ;
Sevick-Muraca, E. M. ;
Sandberg, D. I. ;
Sirianni, R. W. .
ADVANCED DRUG DELIVERY REVIEWS, 2020, 165-166 :77-95
[6]   Surface engineered liposomal delivery of therapeutics across the blood brain barrier: recent advances, challenges and opportunities [J].
Ghosh, Saikat ;
Lalani, Rohan ;
Patel, Vivek ;
Bhowmick, Subhas ;
Misra, Ambikanandan .
EXPERT OPINION ON DRUG DELIVERY, 2019, 16 (12) :1287-1311
[7]   Receptor specific, stimuli responsive and subcellular targeted approaches for effective therapy of Alzheimer: Role of surface engineered nanocarriers [J].
Gopalan, Divya ;
Pandey, Abhijeet ;
Udupa, Nayanabhirama ;
Mutalik, Srinivas .
JOURNAL OF CONTROLLED RELEASE, 2020, 319 :183-200
[8]   Amphiphilic HPMA-LMA copolymers increase the transport of Rhodamine 123 across a BBB model without harming its barrier integrity [J].
Hemmelmann, Mirjam ;
Metz, Verena V. ;
Koynov, Kaloian ;
Blank, Kerstin ;
Postina, Rolf ;
Zentel, Rudolf .
JOURNAL OF CONTROLLED RELEASE, 2012, 163 (02) :170-177
[9]   Mini review on blood-brain barrier penetration of pyridinium aldoximes [J].
Kalasz, H. ;
Nurulain, S. M. ;
Veress, G. ;
Antus, S. ;
Darvas, F. ;
Adeghate, E. ;
Adem, A. ;
Hashemi, F. ;
Tekes, K. .
JOURNAL OF APPLIED TOXICOLOGY, 2015, 35 (02) :116-123
[10]   Time-dependent Changes in Concentration of Two Clinically Used Acetylcholinesterase Reactivators (HI-6 and Obidoxime) in Rat Plasma Determined by HPLC Techniques after in vivo Administration [J].
Karasova, Jana Zdarova ;
Novotny, Ladislav ;
Antos, Karel ;
Zivna, Helena ;
Kuca, Kamil .
ANALYTICAL SCIENCES, 2010, 26 (01) :63-67